Genomma Lab Internacional, S.A.B. de C.V.
GNMLF
$0.93
-$0.03-2.75%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 28.63% | 83.92% | 88.14% | 16.89% | 2.43% |
| Total Depreciation and Amortization | 39.90% | 31.39% | 52.43% | 15.11% | 12.30% |
| Total Amortization of Deferred Charges | -32.64% | -32.64% | -32.64% | 116.45% | 116.45% |
| Total Other Non-Cash Items | -5.57% | 48.67% | 162.34% | 294.78% | 127.14% |
| Change in Net Operating Assets | 82.84% | -220.92% | -213.81% | -266.18% | -33.19% |
| Cash from Operations | 56.96% | 52.70% | 23.44% | 42.30% | 27.42% |
| Capital Expenditure | -95.84% | -39.51% | -5.84% | 44.48% | 45.73% |
| Sale of Property, Plant, and Equipment | 12.88% | -1.01% | 8.86% | 173.52% | -53.22% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -83.88% | -422.59% | -490.44% | -3,965.22% | -421.41% |
| Cash from Investing | -91.60% | -157.05% | -130.29% | -229.23% | -9.37% |
| Total Debt Issued | 29.26% | -17.31% | -22.17% | -41.76% | -44.84% |
| Total Debt Repaid | -12.62% | 23.30% | 24.49% | 29.77% | 37.88% |
| Issuance of Common Stock | -8.24% | -5.87% | -5.87% | 245.22% | 288.02% |
| Repurchase of Common Stock | 9.18% | 12.27% | 12.62% | -184.22% | -111.94% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 36.49% | 7.87% | -28.56% | -6.67% | -49.60% |
| Other Financing Activities | -9.43% | -3.61% | -1.77% | 30.44% | 13.21% |
| Cash from Financing | 58.31% | 30.96% | 8.92% | -125.96% | -71.11% |
| Foreign Exchange rate Adjustments | -170.58% | 1,193.59% | 215.92% | 170.99% | 137.96% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,104.71% | 1,351.37% | 205.00% | -97.04% | -14.92% |